Author
Listed:
- Toru Suzuki
(Laboratory of Mammalian Molecular Embryology, University of Bath)
- Maki Asami
(Laboratory of Mammalian Molecular Embryology, University of Bath)
- Martin Hoffmann
(Project Group Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM)
- Xin Lu
(Experimental Medicine and Therapy Research, University of Regensburg)
- Miodrag Gužvić
(Experimental Medicine and Therapy Research, University of Regensburg)
- Christoph A. Klein
(Project Group Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM
Experimental Medicine and Therapy Research, University of Regensburg)
- Anthony C. F. Perry
(Laboratory of Mammalian Molecular Embryology, University of Bath)
Abstract
Sperm are highly differentiated and the activities that reprogram them for embryonic development during fertilization have historically been considered unique to the oocyte. We here challenge this view and demonstrate that mouse embryos in the mitotic cell cycle can also directly reprogram sperm for full-term development. Developmentally incompetent haploid embryos (parthenogenotes) injected with sperm developed to produce healthy offspring at up to 24% of control rates, depending when in the embryonic cell cycle injection took place. This implies that most of the first embryonic cell cycle can be bypassed in sperm genome reprogramming for full development. Remodelling of histones and genomic 5′-methylcytosine and 5′-hydroxymethylcytosine following embryo injection were distinct from remodelling in fertilization and the resulting 2-cell embryos consistently possessed abnormal transcriptomes. These studies demonstrate plasticity in the reprogramming of terminally differentiated sperm nuclei and suggest that different epigenetic pathways or kinetics can establish totipotency.
Suggested Citation
Toru Suzuki & Maki Asami & Martin Hoffmann & Xin Lu & Miodrag Gužvić & Christoph A. Klein & Anthony C. F. Perry, 2016.
"Mice produced by mitotic reprogramming of sperm injected into haploid parthenogenotes,"
Nature Communications, Nature, vol. 7(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12676
DOI: 10.1038/ncomms12676
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12676. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.